Press Releases

Dec 01, 2023

Real-World Data Presented at SUO 2023 Show that Veracyte’s Decipher Genomic Classifier Identifies Patients Whose Prostate Cancer is Likely to Progress

Read More

Nov 29, 2023

Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodules

Read More

Nov 22, 2023

Veracyte Announces Seven Posters Highlighting Clinical Value of Decipher Prostate Genomic Testing To be Presented at SUO 2023

Read More

Nov 07, 2023

Veracyte Announces Third Quarter 2023 Financial Results

Read More

Nov 07, 2023

Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally

Read More

Nov 02, 2023

Veracyte to Participate in the Stephens Annual Investment Conference

Read More

Oct 27, 2023

Veracyte Announces SITC 2023 Presentations Offering New Insight into Immuno-oncology Drug Development

Read More

Oct 17, 2023

Veracyte to Release Third Quarter 2023 Financial Results on November 7, 2023

Read More

Oct 12, 2023

New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease

Read More

Oct 04, 2023

New Data from Phase 3 Trial Further Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier

Read More